The American Partnership for Eosinophilic Disorders (APFED) is a 501c3 nonprofit organization, founded in 2001 by a group of families impacted by eosinophil-associated diseases. At a time when little information was available about these conditions and the diagnostic journey was long, these pioneers saw the need for community-building, education, awareness, and research support.
APFED’s Mission: To passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy.
Where We Are Headed: APFED strives to be an all-encompassing eosinophilic advocacy organization, representing all eosinophil-associated diseases. By continuing our rich history of cultivating successful working relationships with medical societies and health care providers, researchers, industry, and federal agencies, we strive to bridge the gap between patient and doctor, shortening the journey to diagnoses, increasing research support, supporting new treatments, and one day, a cure.
Our Vision: APFED’s vision is the development of a cure while improving the quality of life for those suffering with eosinophil-associated diseases.
Our Core Values: APFED operates with a passion for improving the lives of those with eosinophil-associated diseases, integrity in all operations, transparency in accordance with nonprofit guidelines, and accuracy with continuous expert review of all educational materials.
For information about research APFED has supported, advocacy progress we've made, or to learn about eosinophil-associated diseases or our organization, visit apfed.org.